Literature DB >> 20079126

Clinical outcomes of percutaneous coronary intervention for chronic total occlusion lesions in remote hospitals without on-site surgical support.

Shao-liang Chen1, Fei Ye, Jun-jie Zhang, Song Lin, Zhong-sheng Zhu, Nai-liang Tian, Zhi-zhong Liu, Xue-wen Sun, Ai-ping Zhang, Feng Chen, Shi-qin Ding, Jack Chen.   

Abstract

BACKGROUND: The safety of percutaneous coronary intervention (PCI) for chronic total occlusion (CTO) lesions in remote hospitals without surgical facilities remains unknown. This study aimed to evaluate three-year outcomes after CTO for PCI in ten centers around China where no on-site coronary artery bypass grafting (CABG) support was available.
METHODS: A total of 152 patients from 10 Chinese hospitals without on-site surgical facilities were prospectively studied. Intra-procedural and in-hospital events were assessed. Angiographic follow-up was indexed eight months after the initial procedure. Clinical follow-up was extended to three years. The primary outcome was the rate of major adverse cardiac events (MACE), defined as cardiac death, myocardial infarction and target-vessel revascularization (TVR).
RESULTS: The incidence of CTO was 7.9% in patients who underwent PCI. Successful recanalization was achieved in 132 patients (86.8%). Compared with patients in the PCI success group, patients with PCI procedural failure had longer lesion lengths ((42.32 +/- 22.08) mm vs (27.61 +/- 22.85) mm, P = 0.023), a higher rate of perforation (25.0% vs 0, P = 0.014), and a greater need for pericardial puncture. There were significant differences in MACE in-hospital and at one year and three years between the failure (10.0%, 30.0% and 35.0%) and the success (3.0%, 12.1% and 14.4%) groups (P = 0.037, 0.034 and 0.040, respectively). These led to a significant decrease in the MACE-free survival rate at one and three years in the failure group, compared with the success group (P = 0.031 and 0.023, respectively). Stump was the only predictor of recanalization success (HR 0.158, 95% CI 0.041-0.612, P = 0.008), whereas procedural failure (OR 13.023, 95% CI 6.67-13.69, P = 0.002), incomplete revascularization (OR 9.71, 95% CI 2.93-5.59, P = 0.005), and total stent length (OR 6.02, 95% CI 1.55-11.93, P = 0.027) were three independent predictors of MACE.
CONCLUSIONS: PCI for CTO was unsafe in remote hospitals without CABG facilities. Paying attention to coronary perforation is important for successful procedures.

Entities:  

Mesh:

Year:  2009        PMID: 20079126

Source DB:  PubMed          Journal:  Chin Med J (Engl)        ISSN: 0366-6999            Impact factor:   2.628


  4 in total

1.  Clinical Utility of the Japan-Chronic Total Occlusion Score in Coronary Chronic Total Occlusion Interventions: Results from a Multicenter Registry.

Authors:  Georgios Christopoulos; R Michael Wyman; Khaldoon Alaswad; Dimitri Karmpaliotis; William Lombardi; J Aaron Grantham; Robert W Yeh; Farouc A Jaffer; Daisha J Cipher; Bavana V Rangan; Georgios E Christakopoulos; Megan A Kypreos; Nicholas Lembo; David Kandzari; Santiago Garcia; Craig A Thompson; Subhash Banerjee; Emmanouil S Brilakis
Journal:  Circ Cardiovasc Interv       Date:  2015-07       Impact factor: 6.546

2.  A Novel Risk Score in Predicting Failure or Success for Antegrade Approach to Percutaneous Coronary Intervention of Chronic Total Occlusion: Antegrade CTO Score.

Authors:  Mohammad Hasan Namazi; Ali Reza Serati; Hosein Vakili; Morteza Safi; Saeed Ali Pour Parsa; Habibollah Saadat; Maryam Taherkhani; Sepideh Emami; Shamseddin Pedari; Masoomeh Vatanparast; Mohammad Reza Movahed
Journal:  Int J Angiol       Date:  2016-10-31

3.  Outcome of Successful Versus Unsuccessful Percutaneous Coronary Intervention in Chronic Total Occlusions in One Year Follow-Up.

Authors:  Bahram Sohrabi; Samad Ghaffari; Afshin Habibzadeh; Parastoo Chaichi; Amir Kamalifar
Journal:  Cardiol Res       Date:  2013-05-09

4.  Meta-analysis of the effect of percutaneous coronary intervention on chronic total coronary occlusions.

Authors:  Ruogu Li; Shuansuo Yang; Lei Tang; Yiqing Yang; Hui Chen; Shaofeng Guan; Wenzheng Han; Hua Liu; Jinjie Dai; Qian Gan; Weiyi Fang; Xinkai Qu
Journal:  J Cardiothorac Surg       Date:  2014-02-28       Impact factor: 1.637

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.